An im­munother­a­py pill for pso­ri­a­sis? Es­calier gets $19M Se­ries B to tack­le R&D

A start­up that’s hop­ing to of­fer pso­ri­a­sis pa­tients a pill to treat their con­di­tion (in­stead of the stan­dard treat­ment of steroids or in­jec­tions) has closed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER